TIMI Investigator and Brigham and Women’s Hospital Interventional Cardiology, Dr. Brian Bergmark, joins Nick and David to discuss the Bridge-TIMI 73a trial and triglyceride lowering therapies.

Dr. Douglas Drachman, Chair of the ACC Scientific Sessions, joins the podcast to preview highlights of the upcoming ACC and to share tips and advice on getting the most out of the conference.

Dr Rasha Al-Lamee, Clinical Academic Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK, joins the podcast to discuss management of angina and the ORBITA trials.

Donna H. Ryan, MD, Professor Emerita at Pennington Biomedical Research Center, joins the podcast to discuss obesity therapies and the results of the SELECT trial.

TIMI turning 40 | Exciting Storylines in 2024 | A Graveyard of Weight Loss Drugs | Breakthrough of Semaglutide (Ozempic/Weygovy/Rybelsus) | SELECT Trial | Obesity as a Disease | Nick and David’s Podcast Resolutions

TIMI Study Group senior investigator Dr. Michelle O’Donoghue joins the podcast to discuss Lp(a) therapies and the Ocean(a) trials.

Dr. Christian Ruff joins the podcast to discuss Factor XI inhibition and his recent Late-Breaking Clinical Trial presentation at AHA, the AZALEA-TIMI 71 trial.

Dr. Rob Mentz premieres Season 2 and discusses his career and the results of the HEART-FID trial.

Nick Marston and David Berg take a deep dive into ISCHEMIA and ISCHEMIA-EXTEND with renowned clinical trialist (and former Brigham medical resident) Dr. Judith Hochman.

Dr. Robert Harrington, Chair of Medicine at Stanford University, joins Nick and David to discuss his vast experience in clinical trials, leadership, and future technology in RCT’s.

TIMI Senior Investigator Ben Scirica, MD, MPH walks us through cardiometabolic interventions in diabetes and obesity and discusses key trials of GLP-1 RAs.